Abstract
Summary
LPI (LP Information)' newest research report, the “Regenerative Medicine for Cartilage Industry Forecast” looks at past sales and reviews total world Regenerative Medicine for Cartilage sales in 2022, providing a comprehensive analysis by region and market sector of projected Regenerative Medicine for Cartilage sales for 2023 through 2029. With Regenerative Medicine for Cartilage sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Regenerative Medicine for Cartilage industry.
This Insight Report provides a comprehensive analysis of the global Regenerative Medicine for Cartilage landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Regenerative Medicine for Cartilage portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Regenerative Medicine for Cartilage market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Regenerative Medicine for Cartilage and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Regenerative Medicine for Cartilage.
The global Regenerative Medicine for Cartilage market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Regenerative Medicine for Cartilage players cover B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC and BioTissue Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Regenerative Medicine for Cartilage market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cell-based
Non-cell-based
Segmentation by application
Hyaline Cartilage Repair and Regeneration
Elastic Cartilage Repair and Regeneration
Ribrous Cartilage Repair and Regeneration.
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
B. Braun Melsungen AG
Zimmer Biomet Holdings Inc.
Vericel Corporation
Stryker Corporation
Smith & Nephew plc
Arthrex Inc.
CONMED Corporation
Collagen Solutions PLC
BioTissue Technologies
CellGenix
This Insight Report provides a comprehensive analysis of the global Regenerative Medicine for Cartilage landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Regenerative Medicine for Cartilage portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Regenerative Medicine for Cartilage market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Regenerative Medicine for Cartilage and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Regenerative Medicine for Cartilage.
The global Regenerative Medicine for Cartilage market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Regenerative Medicine for Cartilage players cover B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC and BioTissue Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Regenerative Medicine for Cartilage market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cell-based
Non-cell-based
Segmentation by application
Hyaline Cartilage Repair and Regeneration
Elastic Cartilage Repair and Regeneration
Ribrous Cartilage Repair and Regeneration.
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
B. Braun Melsungen AG
Zimmer Biomet Holdings Inc.
Vericel Corporation
Stryker Corporation
Smith & Nephew plc
Arthrex Inc.
CONMED Corporation
Collagen Solutions PLC
BioTissue Technologies
CellGenix
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Regenerative Medicine for Cartilage Market Size 2018-2029
2.1.2 Regenerative Medicine for Cartilage Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Regenerative Medicine for Cartilage Segment by Type
2.2.1 Cell-based
2.2.2 Non-cell-based
2.3 Regenerative Medicine for Cartilage Market Size by Type
2.3.1 Regenerative Medicine for Cartilage Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023)
2.4 Regenerative Medicine for Cartilage Segment by Application
2.4.1 Hyaline Cartilage Repair and Regeneration
2.4.2 Elastic Cartilage Repair and Regeneration
2.4.3 Ribrous Cartilage Repair and Regeneration.
2.5 Regenerative Medicine for Cartilage Market Size by Application
2.5.1 Regenerative Medicine for Cartilage Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023)
3 Regenerative Medicine for Cartilage Market Size by Player
3.1 Regenerative Medicine for Cartilage Market Size Market Share by Players
3.1.1 Global Regenerative Medicine for Cartilage Revenue by Players (2018-2023)
3.1.2 Global Regenerative Medicine for Cartilage Revenue Market Share by Players (2018-2023)
3.2 Global Regenerative Medicine for Cartilage Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Regenerative Medicine for Cartilage by Regions
4.1 Regenerative Medicine for Cartilage Market Size by Regions (2018-2023)
4.2 Americas Regenerative Medicine for Cartilage Market Size Growth (2018-2023)
4.3 APAC Regenerative Medicine for Cartilage Market Size Growth (2018-2023)
4.4 Europe Regenerative Medicine for Cartilage Market Size Growth (2018-2023)
4.5 Middle East & Africa Regenerative Medicine for Cartilage Market Size Growth (2018-2023)
5 Americas
5.1 Americas Regenerative Medicine for Cartilage Market Size by Country (2018-2023)
5.2 Americas Regenerative Medicine for Cartilage Market Size by Type (2018-2023)
5.3 Americas Regenerative Medicine for Cartilage Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Regenerative Medicine for Cartilage Market Size by Region (2018-2023)
6.2 APAC Regenerative Medicine for Cartilage Market Size by Type (2018-2023)
6.3 APAC Regenerative Medicine for Cartilage Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Regenerative Medicine for Cartilage by Country (2018-2023)
7.2 Europe Regenerative Medicine for Cartilage Market Size by Type (2018-2023)
7.3 Europe Regenerative Medicine for Cartilage Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Regenerative Medicine for Cartilage by Region (2018-2023)
8.2 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type (2018-2023)
8.3 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Regenerative Medicine for Cartilage Market Forecast
10.1 Global Regenerative Medicine for Cartilage Forecast by Regions (2024-2029)
10.1.1 Global Regenerative Medicine for Cartilage Forecast by Regions (2024-2029)
10.1.2 Americas Regenerative Medicine for Cartilage Forecast
10.1.3 APAC Regenerative Medicine for Cartilage Forecast
10.1.4 Europe Regenerative Medicine for Cartilage Forecast
10.1.5 Middle East & Africa Regenerative Medicine for Cartilage Forecast
10.2 Americas Regenerative Medicine for Cartilage Forecast by Country (2024-2029)
10.2.1 United States Regenerative Medicine for Cartilage Market Forecast
10.2.2 Canada Regenerative Medicine for Cartilage Market Forecast
10.2.3 Mexico Regenerative Medicine for Cartilage Market Forecast
10.2.4 Brazil Regenerative Medicine for Cartilage Market Forecast
10.3 APAC Regenerative Medicine for Cartilage Forecast by Region (2024-2029)
10.3.1 China Regenerative Medicine for Cartilage Market Forecast
10.3.2 Japan Regenerative Medicine for Cartilage Market Forecast
10.3.3 Korea Regenerative Medicine for Cartilage Market Forecast
10.3.4 Southeast Asia Regenerative Medicine for Cartilage Market Forecast
10.3.5 India Regenerative Medicine for Cartilage Market Forecast
10.3.6 Australia Regenerative Medicine for Cartilage Market Forecast
10.4 Europe Regenerative Medicine for Cartilage Forecast by Country (2024-2029)
10.4.1 Germany Regenerative Medicine for Cartilage Market Forecast
10.4.2 France Regenerative Medicine for Cartilage Market Forecast
10.4.3 UK Regenerative Medicine for Cartilage Market Forecast
10.4.4 Italy Regenerative Medicine for Cartilage Market Forecast
10.4.5 Russia Regenerative Medicine for Cartilage Market Forecast
10.5 Middle East & Africa Regenerative Medicine for Cartilage Forecast by Region (2024-2029)
10.5.1 Egypt Regenerative Medicine for Cartilage Market Forecast
10.5.2 South Africa Regenerative Medicine for Cartilage Market Forecast
10.5.3 Israel Regenerative Medicine for Cartilage Market Forecast
10.5.4 Turkey Regenerative Medicine for Cartilage Market Forecast
10.5.5 GCC Countries Regenerative Medicine for Cartilage Market Forecast
10.6 Global Regenerative Medicine for Cartilage Forecast by Type (2024-2029)
10.7 Global Regenerative Medicine for Cartilage Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Company Information
11.1.2 B. Braun Melsungen AG Regenerative Medicine for Cartilage Product Offered
11.1.3 B. Braun Melsungen AG Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 B. Braun Melsungen AG Main Business Overview
11.1.5 B. Braun Melsungen AG Latest Developments
11.2 Zimmer Biomet Holdings Inc.
11.2.1 Zimmer Biomet Holdings Inc. Company Information
11.2.2 Zimmer Biomet Holdings Inc. Regenerative Medicine for Cartilage Product Offered
11.2.3 Zimmer Biomet Holdings Inc. Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Zimmer Biomet Holdings Inc. Main Business Overview
11.2.5 Zimmer Biomet Holdings Inc. Latest Developments
11.3 Vericel Corporation
11.3.1 Vericel Corporation Company Information
11.3.2 Vericel Corporation Regenerative Medicine for Cartilage Product Offered
11.3.3 Vericel Corporation Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Vericel Corporation Main Business Overview
11.3.5 Vericel Corporation Latest Developments
11.4 Stryker Corporation
11.4.1 Stryker Corporation Company Information
11.4.2 Stryker Corporation Regenerative Medicine for Cartilage Product Offered
11.4.3 Stryker Corporation Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Stryker Corporation Main Business Overview
11.4.5 Stryker Corporation Latest Developments
11.5 Smith & Nephew plc
11.5.1 Smith & Nephew plc Company Information
11.5.2 Smith & Nephew plc Regenerative Medicine for Cartilage Product Offered
11.5.3 Smith & Nephew plc Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Smith & Nephew plc Main Business Overview
11.5.5 Smith & Nephew plc Latest Developments
11.6 Arthrex Inc.
11.6.1 Arthrex Inc. Company Information
11.6.2 Arthrex Inc. Regenerative Medicine for Cartilage Product Offered
11.6.3 Arthrex Inc. Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Arthrex Inc. Main Business Overview
11.6.5 Arthrex Inc. Latest Developments
11.7 CONMED Corporation
11.7.1 CONMED Corporation Company Information
11.7.2 CONMED Corporation Regenerative Medicine for Cartilage Product Offered
11.7.3 CONMED Corporation Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CONMED Corporation Main Business Overview
11.7.5 CONMED Corporation Latest Developments
11.8 Collagen Solutions PLC
11.8.1 Collagen Solutions PLC Company Information
11.8.2 Collagen Solutions PLC Regenerative Medicine for Cartilage Product Offered
11.8.3 Collagen Solutions PLC Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Collagen Solutions PLC Main Business Overview
11.8.5 Collagen Solutions PLC Latest Developments
11.9 BioTissue Technologies
11.9.1 BioTissue Technologies Company Information
11.9.2 BioTissue Technologies Regenerative Medicine for Cartilage Product Offered
11.9.3 BioTissue Technologies Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BioTissue Technologies Main Business Overview
11.9.5 BioTissue Technologies Latest Developments
11.10 CellGenix
11.10.1 CellGenix Company Information
11.10.2 CellGenix Regenerative Medicine for Cartilage Product Offered
11.10.3 CellGenix Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 CellGenix Main Business Overview
11.10.5 CellGenix Latest Developments
12 Research Findings and Conclusion